Node-positive Nonmetastatic Prostate Cancer: Time to Reconsider Prognostic Staging?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 30262339.
- Also identified by DOI 10.1016/j.eururo.2018.09.017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Node-positive nonmetastatic prostate cancer is currently prognosticated as stage IV, despite evidence that a proportion of this patient population can be cured. We provide evidence and request reconsideration of prognostic staging in the next edition of the American Joint Committee on Cancer staging manual.
Medical subject headings
- Lymph Nodes
- Neoplasm Staging
- Prostatic Neoplasms